BERNADETTE HUVANE: Open Payments
NPI 1285761270 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,040 in 8 payments from 8 companies in 2025. Trend: 2023 $250 · 2024 $240 · 2025 $1,040
Food & beverage: $1,040
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| Abbott Laboratories | 1 | $146 |
| bioMerieux Inc | 1 | $142 |
| UCB, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $124 |
| Eisai Inc. | 1 | $103 |
Products named: REZDIFFRA, FREESTYLE LIBRE 3, BIOFIRE RESPIRATORY PANEL 2.1, Nayzilam, Auvelity, JARDIANCE, ENTYVIO, Leqembi.
Industry payments across NY — which companies pay providers there.
